Hyperfine, Inc. Form 8-K Summary
Business Context and Reporting Period
Hyperfine filed a Form 8-K dated January 10, 2022, under Items 2.02, 7.01, and 9.01. The filing announced preliminary unaudited financial information for the quarter and year ended December 31, 2021, together with business and operating updates. The filing relates to Hyperfine’s medical technology business; the provided text does not include the accompanying press release or corporate presentation details.
Financial Metrics
- Preliminary unaudited total revenue was reported for the quarter ended December 31, 2021, and the year ended December 31, 2021.
- The filing text does not provide clear revenue amounts.
- No figures for profit or loss, cash flow, gross or operating margins, debt, liquidity, cash balance, or other financial metrics are included in the provided filing text.
Material Changes Versus Prior Period
The filing indicates that year-end and fourth-quarter preliminary revenue information was released, but it does not provide sufficient figures or comparisons to determine material changes versus the prior comparable periods.
Guidance, Outlook, Risks, and Unusual Items
- Hyperfine updated its corporate presentation and made it available through the Investors section of its website.
- The filing text does not state specific financial guidance, forecasts, management targets, or outlook figures.
- No specific risks, contingencies, unusual items, or nonrecurring charges are described in the provided text.
- The disclosed financial information is preliminary and unaudited and may change upon completion of the company’s closing and audit processes.
- The press release and corporate presentation were furnished as Exhibits 99.1 and 99.2. The information in the Form 8-K was generally furnished, rather than filed, for purposes of Section 18 of the Exchange Act.
Investor Verification Items
- Verify the preliminary fourth-quarter and full-year 2021 revenue amounts in Exhibits 99.1 and 99.2.
- Confirm the final audited 2021 results, including losses, cash flow, cash and equivalents, debt, and liquidity.
- Review the corporate presentation for operating metrics, installed systems, commercial progress, guidance, and management commentary.
- Compare final 2021 results with 2020 and subsequent quarterly filings to assess growth and changing financial trends.